BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Deals

  NED Biosystems Raises $2 Million in Series B Financing Round and Appoints New CEO

  Company Announces New Members to Scientific Advisory Board

  August 1, 2018

   · 

  4 min read
• Pharm Country

  Newron Pharmaceuticals to Present at Wedbush PacGrow Healthcare Conference

  Newron Pharmaceuticals S.p.A. announced that Stefan Weber, CEO, will present at the Wedbush PacGrow Healthcare Conference in New York, NY, on Wednesday, August 15, 2018 at 1:20 p.m. ET.

  August 1, 2018

   · 

  1 min read
• Biotech Beach

  Immune Advisors Publishes Peer-Reviewed Study Demonstrating Efficacy of a Probiotic and Digestive Enzymes Supplement in Protecting Against Side Effects of Cancer Chemotherapy

  Immunotherapy Focused Consulting Company Provides Independent Support of the Value of Daily Body Restore® for Cancer Patients

  August 1, 2018

   · 

  3 min read
• Business

  The Medicines Company Reports Second-Quarter 2018 Results

  The Medicines Company (NASDAQ:MDCO) today reported its financial results for the second quarter ended June 30, 2018.

  August 1, 2018

   · 

  16 min read
• Biotech Beach

  Imprimis Announces Multi-Center Clinical Trial for Dropless® TriMoxi™ (Triamcinolone Acetonide-Moxifloxacin for injection) Formulation in Canada

  Study to assess drug safety, patient preference and pharmacoeconomic measures in 200 routine cataract surgeries

  August 1, 2018

   · 

  6 min read
• Business

  Rigel Announces Conference Call and Webcast to Report Second Quarter 2018 Financial Results

  Rigel Pharmaceuticals, Inc. announced that it will report its second quarter 2018 financial results after market close on Wednesday, August 8, 2018.

  August 1, 2018

   · 

  1 min read
• Business

  Aerie Pharmaceuticals to Announce Second Quarter 2018 Financial Results and Host Conference Call on Wednesday, August 8, 2018

  Aerie Pharmaceuticals, Inc. announced today that its second quarter 2018 financial results will be released after the market closes on Wednesday, August 8, 2018.

  August 1, 2018

   · 

  2 min read
• Business

  Dicerna to Report Second Quarter 2018 Financial Results and Host Conference Call on August 8, 2018

  Dicerna Pharmaceuticals, Inc. announced that the Company will release its second quarter 2018 financial results after market close on Wednesday, August 8, 2018.

  August 1, 2018

   · 

  1 min read
• Biotech Beach

  Forge Achieves CARB-X Milestone To Advance Its LpxC Antibiotic To Treat Infections Caused By The World’s Deadliest ‘Superbugs’

  -Technical milestone achievement and program advancement from initial round of ‘Powered by CARB-X’ products-

  August 1, 2018

   · 

  5 min read
• FDA

  FDA Grants Breakthrough Therapy Designation to Daiichi Sankyo’s FLT3 Inhibitor Quizartinib for Relapsed/Refractory FLT3-ITD AML

  Quizartinib has received FDA Breakthrough Therapy designation in patients with relapsed/refractory FLT3-ITD AML, a very aggressive form of the disease associated with poor prognosis

  August 1, 2018

   · 

  6 min read